Literature DB >> 16585585

TLR3 can directly trigger apoptosis in human cancer cells.

Bruno Salaun1, Isabelle Coste, Marie-Clotilde Rissoan, Serge J Lebecque, Toufic Renno.   

Abstract

TLRs function as molecular sensors to detect pathogen-derived products and trigger protective responses ranging from secretion of cytokines that increase the resistance of infected cells and chemokines that recruit immune cells to cell death that limits microbe spreading. Viral dsRNA participate in virus-infected cell apoptosis, but the signaling pathway involved remains unclear. In this study we show that synthetic dsRNA induces apoptosis of human breast cancer cells in a TLR3-dependent manner, which involves the molecular adaptor Toll/IL-1R domain-containing adapter inducing IFN-beta and type I IFN autocrine signaling, but occurs independently of the dsRNA-activated kinase. Moreover, detailed molecular analysis of dsRNA-induced cell death established the proapoptotic role of IL-1R-associated kinase-4 and NF-kappaB downstream of TLR3 as well as the activation of the extrinsic caspases. The direct proapoptotic activity of endogenous human TLR3 expressed by cancerous cells reveals a novel aspect of the multiple-faced TLR biology, which may open new clinical prospects for using TLR3 agonists as cytotoxic agents in selected cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585585     DOI: 10.4049/jimmunol.176.8.4894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  175 in total

Review 1.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

Review 2.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

3.  Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth.

Authors:  Zhenyu Cai; Amir Sanchez; Zhongcheng Shi; Tingting Zhang; Mingyao Liu; Dekai Zhang
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

4.  Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics.

Authors:  Danielle N Van; Charlotte F Roberts; James D Marion; Sandrine Lépine; Kuzhuvelil B Harikumar; Jessica Schreiter; Catherine I Dumur; Xianjun Fang; Sarah Spiegel; Jessica K Bell
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

5.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

6.  Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation.

Authors:  Lei Fan; Peng Zhou; Qi Hong; Ao-Xiang Chen; Guang-Yu Liu; Ke-Da Yu; Zhi-Ming Shao
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

Review 7.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

8.  Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis.

Authors:  Luc Friboulet; Catherine Pioche-Durieu; Sandrine Rodriguez; Alexander Valent; Sylvie Souquère; Hugues Ripoche; Abdelmajid Khabir; Sai Wah Tsao; Jacques Bosq; Kwok Wai Lo; Pierre Busson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.

Authors:  Christopher D Scharer; Colleen D McCabe; Mohamed Ali-Seyed; Michael F Berger; Martha L Bulyk; Carlos S Moreno
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 10.  The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Authors:  Lana E Kandalaft; Nathan Singh; John B Liao; Andrea Facciabene; Jonathan S Berek; Daniel J Powell; George Coukos
Journal:  Gynecol Oncol       Date:  2009-12-02       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.